163 related articles for article (PubMed ID: 34407041)
21. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
[TBL] [Abstract][Full Text] [Related]
22. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
[No Abstract] [Full Text] [Related]
23. Effective management strategies for patients with marginal zone lymphoma.
Rosand CB; Valla K; Flowers CR; Koff JL
Future Oncol; 2018 May; 14(12):1213-1222. PubMed ID: 29260925
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
[TBL] [Abstract][Full Text] [Related]
25. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
[TBL] [Abstract][Full Text] [Related]
26. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
[TBL] [Abstract][Full Text] [Related]
27. Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.
Cervetti G; Galimberti S; Pelosini M; Ghio F; Cecconi N; Petrini M
Ann Oncol; 2013 Sep; 24(9):2434-8. PubMed ID: 23712547
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of splenic marginal zone lymphoma.
Kennedy ND; Lê GN; Kelly ME; Harding T; Fadalla K; Winter DC
Ir J Med Sci; 2018 May; 187(2):343-347. PubMed ID: 29043543
[TBL] [Abstract][Full Text] [Related]
30. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
31. [Splenic marginal zone lymphoma].
Dimopoulos K; Pedersen M
Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
[TBL] [Abstract][Full Text] [Related]
32. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
[TBL] [Abstract][Full Text] [Related]
33. Non-MALT marginal zone lymphomas.
Thieblemont C
Ann Oncol; 2008 Jun; 19 Suppl 4():iv70-3. PubMed ID: 18519410
[No Abstract] [Full Text] [Related]
34. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
[TBL] [Abstract][Full Text] [Related]
35. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
[TBL] [Abstract][Full Text] [Related]
36. Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Muntañola A; Villalobos MT; González-Villambrosia S; Rodríguez-Salazar MJ; Jiménez-Ubieto A; Bastidas-Mora G; Córdoba R; Infante M; Vidal MJ; Díaz FJ; Baile M; Bastos-Oreiro M; Panizo C; Sancho JM; Navarro B; García T; Escoda L; Abrisqueta P; Terol MJ; de Campo R; Mozas P; López-Guillermo A; Salar A; Montalbán C;
Br J Haematol; 2023 Aug; 202(4):776-784. PubMed ID: 37386877
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
[TBL] [Abstract][Full Text] [Related]
38. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
[TBL] [Abstract][Full Text] [Related]
39. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
40. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]